Figure 3.
The eye of a patient treated with the low-dose (A) shows fine keratitic precipitates (B). A second patient treated with the medium dose shows keratitic precipitates (C) that resolved one month later (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.